Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer.

Kaidar-Person O, Vrou Offersen B, Hol S, Arenas M, Aristei C, Bourgier C, Cardoso MJ, Chua B, Coles CE, Engberg Damsgaard T, Gabrys D, Jagsi R, Jimenez R, Kirby AM, Kirkove C, Kirova Y, Kouloulias V, Marinko T, Meattini I, Mjaaland I, Nader Marta G, Witt Nystrom P, Senkus E, Skyttä T, Tvedskov TF, Verhoeven K, Poortmans P.

Radiother Oncol. 2019 Aug;137:159-166. doi: 10.1016/j.radonc.2019.04.010. Epub 2019 May 17.

PMID:
31108277
2.

Rock Physical Controls on Production-induced Compaction in the Groningen Field.

Hol S, van der Linden A, Bierman S, Marcelis F, Makurat A.

Sci Rep. 2018 May 8;8(1):7156. doi: 10.1038/s41598-018-25455-z.

3.

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1.

Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Sola AB, Kirova YM, Pignol JP, Remouchamps V, Verhoeven K, Weltens C, Arenas M, Gabrys D, Kopek N, Krause M, Lundstedt D, Marinko T, Montero A, Yarnold J, Poortmans P.

Radiother Oncol. 2016 Jan;118(1):205-8. doi: 10.1016/j.radonc.2015.12.027. Epub 2016 Jan 18. No abstract available.

PMID:
26791404
4.

Should breathing adapted radiotherapy also be applied for right-sided breast irradiation?

Essers M, Poortmans PM, Verschueren K, Hol S, Cobben DC.

Acta Oncol. 2016;55(4):460-5. doi: 10.3109/0284186X.2015.1102321. Epub 2015 Oct 27.

PMID:
26503610
5.

Untouched GMP-Ready Purified Engineered Immune Cells to Treat Cancer.

Straetemans T, Gründer C, Heijhuurs S, Hol S, Slaper-Cortenbach I, Bönig H, Sebestyen Z, Kuball J.

Clin Cancer Res. 2015 Sep 1;21(17):3957-68. doi: 10.1158/1078-0432.CCR-14-2860. Epub 2015 May 19.

6.

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer.

Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Biete Sola A, Kirova YM, Pignol JP, Remouchamps V, Verhoeven K, Weltens C, Arenas M, Gabrys D, Kopek N, Krause M, Lundstedt D, Marinko T, Montero A, Yarnold J, Poortmans P.

Radiother Oncol. 2015 Jan;114(1):3-10. doi: 10.1016/j.radonc.2014.11.030. Epub 2015 Jan 24.

PMID:
25630428
7.

A rationale for reduced-frequency dosing of anidulafungin for antifungal prophylaxis in immunocompromised patients.

Brüggemann RJ, Van Der Velden WJ, Knibbe CA, Colbers A, Hol S, Burger DM, Donnelly JP, Blijlevens NM.

J Antimicrob Chemother. 2015 Apr;70(4):1166-74. doi: 10.1093/jac/dku477. Epub 2014 Dec 3.

PMID:
25473029
8.

Volumetric modulated arc therapy and breath-hold in image-guided locoregional left-sided breast irradiation.

Osman SO, Hol S, Poortmans PM, Essers M.

Radiother Oncol. 2014 Jul;112(1):17-22. doi: 10.1016/j.radonc.2014.04.004. Epub 2014 May 10.

PMID:
24825176
9.

Accelerated partial breast irradiation (APBI): are breath-hold and volumetric radiation therapy techniques useful?

Essers M, Osman SO, Hol S, Donkers T, Poortmans PM.

Acta Oncol. 2014 Jun;53(6):788-94. doi: 10.3109/0284186X.2014.887226. Epub 2014 Apr 1.

PMID:
24689645
10.

Reply: Concepts of arterial oxygen saturation in the presence of carboxyhemoglobin.

Kemperman H, van Solinge WW, Hol S, van der Spoel JI, de Vooght KM.

Am J Respir Crit Care Med. 2013 Sep 15;188(6):750. doi: 10.1164/rccm.201302-0393LE. No abstract available.

PMID:
24032385
12.

γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia.

Scheper W, van Dorp S, Kersting S, Pietersma F, Lindemans C, Hol S, Heijhuurs S, Sebestyen Z, Gründer C, Marcu-Malina V, Marchant A, Donner C, Plachter B, Vermijlen D, van Baarle D, Kuball J.

Leukemia. 2013 Jun;27(6):1328-38. doi: 10.1038/leu.2012.374. Epub 2013 Jan 1.

PMID:
23277330
13.

A 56-year-old man with an apparently normal oxygen saturation and a dead canary.

Hol S, de Vooght KM, van der Spoel JJ, van Solinge WW, Kemperman H.

Am J Respir Crit Care Med. 2012 Nov 1;186(9):928-9. No abstract available.

PMID:
23118086
14.

γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs.

Gründer C, van Dorp S, Hol S, Drent E, Straetemans T, Heijhuurs S, Scholten K, Scheper W, Sebestyen Z, Martens A, Strong R, Kuball J.

Blood. 2012 Dec 20;120(26):5153-62. doi: 10.1182/blood-2012-05-432427. Epub 2012 Sep 27.

15.

Patient positioning based on a radioactive tracer implanted in patients with localized prostate cancer: a performance and safety evaluation.

de Kruijf WJ, Verstraete J, Neustadter D, Corn BW, Hol S, Venselaar JL, Davits RJ, Wijsman BP, Van den Bergh L, Budiharto T, Oyen R, Haustermans K, Poortmans PM.

Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):555-60. doi: 10.1016/j.ijrobp.2012.03.064. Epub 2012 May 30.

PMID:
22652103
16.

Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis.

Hoedemakers RM, Pruijt JF, Hol S, Teunissen E, Martens H, Stam P, Melsert R, Te Velthuis H.

Clin Chem Lab Med. 2011 Nov 23;50(3):489-95. doi: 10.1515/CCLM.2011.793.

PMID:
22098433
17.

Aerial dissemination of Clostridium difficile on a pig farm and its environment.

Keessen EC, Donswijk CJ, Hol SP, Hermanus C, Kuijper EJ, Lipman LJ.

Environ Res. 2011 Nov;111(8):1027-32. doi: 10.1016/j.envres.2011.09.014. Epub 2011 Oct 19.

PMID:
22014605
18.

N Latex FLC - new monoclonal high-performance assays for the determination of free light chain kappa and lambda.

te Velthuis H, Knop I, Stam P, van den Broek M, Bos HK, Hol S, Teunissen E, Fischedick KS, Althaus H, Schmidt B, Wagner C, Melsert R.

Clin Chem Lab Med. 2011 Aug;49(8):1323-32. doi: 10.1515/CCLM.2011.624. Epub 2011 Jun 10.

PMID:
21663464
19.

Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909.

Kuball J, de Boer K, Wagner E, Wattad M, Antunes E, Weeratna RD, Vicari AP, Lotz C, van Dorp S, Hol S, Greenberg PD, Heit W, Davis HL, Theobald M.

Cancer Immunol Immunother. 2011 Feb;60(2):161-71. doi: 10.1007/s00262-010-0929-7. Epub 2010 Oct 21.

20.

HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20 low expressing tumor cells that resist rituximab-mediated lysis.

van Meerten T, Rozemuller H, Hol S, Moerer P, Zwart M, Hagenbeek A, Mackus WJ, Parren PW, van de Winkel JG, Ebeling SB, Martens AC.

Haematologica. 2010 Dec;95(12):2063-71. doi: 10.3324/haematol.2010.025783. Epub 2010 Sep 17.

21.

Competition for light between toxic and nontoxic strains of the harmful cyanobacterium Microcystis.

Kardinaal WE, Tonk L, Janse I, Hol S, Slot P, Huisman J, Visser PM.

Appl Environ Microbiol. 2007 May;73(9):2939-46. Epub 2007 Mar 2.

22.

Complement-induced cell death by rituximab depends on CD20 expression level and acts complementary to antibody-dependent cellular cytotoxicity.

van Meerten T, van Rijn RS, Hol S, Hagenbeek A, Ebeling SB.

Clin Cancer Res. 2006 Jul 1;12(13):4027-35.

23.

T cell receptor-transgenic primary T cells as a tool for discovery of leukaemia-associated antigens.

Ivanov R, Hol S, Aarts TI, Hagenbeek A, Ebeling SB.

Clin Exp Immunol. 2006 Jan;143(1):78-84.

24.
25.

UTY-specific TCR-transfer generates potential graft-versus-leukaemia effector T cells.

Ivanov R, Hol S, Aarts T, Hagenbeek A, Slager EH, Ebeling S.

Br J Haematol. 2005 May;129(3):392-402.

PMID:
15842664
26.

Identification of a 40S ribosomal protein S4-derived H-Y epitope able to elicit a lymphoblast-specific cytotoxic T lymphocyte response.

Ivanov R, Aarts T, Hol S, Doornenbal A, Hagenbeek A, Petersen E, Ebeling S.

Clin Cancer Res. 2005 Mar 1;11(5):1694-703.

27.

HLA-DRB1*16-restricted recognition of myeloid cells, including CD34+ CML progenitor cells.

Ebeling SB, Ivanov R, Hol S, Aarts TI, Hagenbeek A, Verdonck LF, Petersen EJ.

Br J Haematol. 2003 Jun;121(5):721-9.

PMID:
12780786
28.

Development and application of quantitative real time PCR and RT-PCR assays that discriminate between the full-length and truncated herpes simplex virus thymidine kinase gene.

Ebeling SB, Eric Borst HP, Simonetti ER, Hol S, Garin MI, Slaper-Cortenbach I, Hagenbeek A.

J Virol Methods. 2003 May;109(2):177-86.

PMID:
12711061
29.

The genes encoding the peripheral cannabinoid receptor and alpha-L-fucosidase are located near a newly identified common virus integration site, Evi11.

Valk PJ, Hol S, Vankan Y, Ihle JN, Askew D, Jenkins NA, Gilbert DJ, Copeland NG, de Both NJ, Löwenberg B, Delwel R.

J Virol. 1997 Sep;71(9):6796-804.

30.

Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells.

Valk P, Verbakel S, Vankan Y, Hol S, Mancham S, Ploemacher R, Mayen A, Löwenberg B, Delwel R.

Blood. 1997 Aug 15;90(4):1448-57.

Supplemental Content

Support Center